New York Post
Artificial intelligence has developed a treatment for cancer in just 30 days and can predict a patient’s survival rate.
In a new study published in the journal Chemical Science, researchers at the University of Toronto along with Insilico Medicine developed a potential treatment for hepatocellular carcinoma (HCC) with an AI drug discovery platform called Pharma.AI.
HCC is the most common type of liver cancer and occurs when a tumor grows on the liver, according to Cleveland Clinic.